# A Research Study for Patients With Prostate Cancer

> **NCT00106418** · PHASE2 · COMPLETED · sponsor: **Celgene** · enrollment: 35 (actual)

## Conditions studied

- Prostate Cancer
- Metastases

## Interventions

- **DRUG:** Romidepsin

## Key facts

- **NCT ID:** NCT00106418
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05-07
- **Primary completion:** 2006-09-01
- **Final completion:** 2006-09-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2019-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00106418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00106418, "A Research Study for Patients With Prostate Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00106418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*